Kraig Biocraft Laboratories Announces Results of 2013 Meeting of Shareholders
April 17 2013 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the "Company"), the
leading developer of advanced spider silk based fibers, announced
today that all of the Board of Director's proposals were approved
at its meeting of shareholders held yesterday in Lansing, Michigan.
All three amendments to Company's charter listed on the meeting
agenda passed with unanimous attending shareholder
approval. The amendments were designed to help management
advance the business model in a more streamlined fashion.
"The overwhelming support of the attending shareholders,
expressed over nearly four hours of discussions, and the unanimous
vote on all of management's proposals, is a validation of our plans
for production and commercialization," said CEO and founder Kim
Thompson. "I am looking forward to communicating further
details of our plans and progress to the shareholders in an
upcoming shareholder conference call."
"I would like to thank the shareholders who were able to take
time out of their busy schedules to attend the meeting," continued
Thompson. "It was extremely gratifying to meet other
shareholders, who share many of the same visions and goals for the
Company and the technology."
A copy of the three amendments to the Company charter which were
approved by the shareholders at yesterday's meeting is available on
the Company's website under the notice of meeting section.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024